XML 78 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Taxes  
Schedule of components of income tax expense

Year Ended December 31, 

    

2021

    

2022

    

2023

US$

US$

US$

Loss before tax

 

  

 

  

Loss from PRC entities

 

(150,478)

 

(143,951)

(71,249)

(Loss)/profit from overseas entities

 

(24,456)

 

(344)

14,183

Total loss before tax

 

(174,934)

 

(144,295)

(57,066)

Year Ended December 31, 

    

2021

    

2022

    

2023

US$

US$

US$

Current income tax expense

 

490

 

1,880

3,249

Deferred income tax

 

 

Total income tax expense

 

490

 

1,880

3,249

Schedule of reconciliation of differences between statutory tax rate and effective tax rate

Year Ended December 31, 

 

    

2021

    

2022

    

2023

 

PRC Statutory income tax rate

 

25.0

%

25.0

%

25.0

%

Effect of tax rates in different tax jurisdiction

 

(2.0)

%

(0.3)

%

(2.5)

%

Effect of preferential tax rate for qualified HNTE entities (1)

 

(2.2)

%

(6.0)

%

(5.4)

%

Additional deduction for research and development expenditures

 

7.2

%

8.5

%

17.7

%

Share-based compensation expenses

(8.4)

%

(10.5)

%  

(19.7)

%  

Permanent book-tax differences

6.2

%  

(1.4)

%  

1.6

%  

Change in valuation allowance (2)

(26.0)

%  

(16.6)

%  

(22.4)

%  

Effective tax rates

(0.2)

%  

(1.3)

%  

(5.7)

%  

(1)The effect of the preferential income tax rate that the WFOE is entitled to enjoy as a qualified HNTE is 15%.
(2)Valuation allowance for the years ended December 31, 2021, 2022 and 2023 are related to the deferred tax assets of certain group entities which reported losses. The Group believes that it is more likely than not that the deferred tax assets of these entities will not be utilized. Therefore, valuation allowance has been provided.
Summary of deferred tax assets and deferred tax liabilities

    

As of December 31, 

    

2021

    

2022

    

2023

US$

US$

US$

Deferred tax assets

 

 

Net accumulated losses-carry forward

 

76,944

 

103,231

114,958

Payroll liabilities

 

5,438

 

2,915

2,451

Credit-related impairment of long-term investments

1,421

Inventory write-downs

 

402

 

691

531

Receivables allowances

 

171

 

42

279

Other deductible temporary difference

 

9

 

88

106

Less: valuation allowance

 

(82,964)

 

(106,967)

(119,746)

Total deferred tax assets

 

 

Summary of tax losses carry forwarded for future years

At December 31, 2023

    

US$

2024

 

227

2025

 

59,719

2026

 

106,030

2027

 

50,463

2028

 

59,405

2029

 

68,687

2030

 

37,607

2031

 

34,690

2032

 

98,215

2033

 

36,502

Total tax losses carry forwards

 

551,545

Schedule of movement of valuation allowance

As of December 31, 

    

2021

    

2022

    

2023

US$

US$

US$

Balance at beginning of the year

 

37,405

 

82,964

106,967

Changes of valuation allowance(1)

 

45,559

 

24,003

12,779

Balance at end of the year

 

82,964

 

106,967

119,746

(1)Valuation allowances have been provided against deferred tax assets when the Group determines that it is more likely than not that the deferred tax assets will not be utilized in the future. In making such determination, the Group evaluates a variety of factors including the Group’s entities’ operating history, accumulated deficit, existence of taxable temporary differences and reversal periods. As of December 31, 2022 and 2023, full valuation allowances on deferred tax assets were provided because it was more likely than not that the Group will not be able to utilize tax loss carry forwards and other temporary tax difference generated by its unprofitable subsidiaries and the VIE.